sildenafil Viagra brand
Selected indexed studies
- A Cost Analysis of Phosphodiesterase Type 5 Inhibitors in the United States. (Urology, 2024) [PMID:37951363]
- A Non-Systemic Phosphodiesterase-5 Inhibitor Suppresses Colon Proliferation in Mice. (Int J Mol Sci, 2023) [PMID:37298349]
- ATR-FTIR characterization of generic brand-named and counterfeit sildenafil- and tadalafil-based tablets found on the Brazilian market. (Sci Justice, 2017) [PMID:28606335]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- A Cost Analysis of Phosphodiesterase Type 5 Inhibitors in the United States. (2024) pubmed
- A Non-Systemic Phosphodiesterase-5 Inhibitor Suppresses Colon Proliferation in Mice. (2023) pubmed
- ATR-FTIR characterization of generic brand-named and counterfeit sildenafil- and tadalafil-based tablets found on the Brazilian market. (2017) pubmed
- Anticounterfeit packaging technologies. (2010) pubmed
- ALERT: Revatio is another brand name for sildenafil. (2009) pubmed
- A web-based survey of UK pharmacists to assess the effectiveness of Viagra Connect(®) additional risk minimisation measures. (2022) pubmed
- Utilization Trends of Phosphodiesterase Type-5 Inhibitors for Erectile Dysfunction Between 2019 and 2023 in Tanzania. (2024) pubmed
- Flavonoids and prenylhydroquinones from the prepared folium of Epimedium sagittatum Maxim. and their inhibition against phosphodiesterase5A. (2023) pubmed
- Retrospective Database Analysis to Explore Patterns and Economic Burden of Switchback to Brand After Generic or Authorized Generic Utilization. (2022) pubmed
- Formulation and bioequivalence of two sildenafil 50 mg film-coated tablets after a single oral administration. (2015) pubmed